Trending Articles

BUY HOLD SELL – Imugene (ASX: IMU)

Imugene (IMU) is expected to move into the ASX 200 in the December quarter rebalance. If that happens, fund managers that are benchmarked to the ASX 200 index must consider buying it, and passive funds have to buy it. It also puts the company on the radar of more investors and research houses. For some…

BUY HOLD SELL – Camplify (ASX: CHL)

The reopening enthusiasm is palpable in Victoria. The sun is shining a little brighter and the air through the thin layer of cotton mask is arguably, sweeter? I was asked to look at a company which has done very well out of reopening activity and closed international borders. Campily (CHL), the business has created an…

BUY HOLD SELL – Nick Scali (ASX: NCK)

The median Sydney house price is rising by nearly $6000 per week. In Melbourne, it is a similar number. Central banks and regulators are stepping in with tougher macro-prudential rules but that isn’t going to going to stop the boom. CBA calculating national prices will rise 7% in 2022 despite APRA’s move to lift serviceability…

BUY HOLD SELL – Cettire (ASX: CTT)

In the instant gratification world, the younger generation lives in today, Instagram, TikTok, cryptocurrencies and NFT’s are the mediums through which a ‘career’ for a very loose use of the word can be formed. Most of them fuel a culture that goes against every financial theory you learn at university. A dollar today is worth…